1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Sepsis Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Sepsis Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Sepsis Diagnostics Market Regional Analysis
6.2 Europe Sepsis Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Europe Sepsis Diagnostics Market Forecast Analysis
7. Europe Sepsis Diagnostics Market Analysis – by Product
7.1 Instruments
- 7.1.1 Overview
- 7.1.2 Instruments: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Reagents and Assays
- 7.2.1 Overview
- 7.2.2 Reagents and Assays: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Blood Culture Media
- 7.3.1 Overview
- 7.3.2 Blood Culture Media: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Software
- 7.4.1 Overview
- 7.4.2 Software: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Sepsis Diagnostics Market Analysis – by Technology
8.1 Molecular Diagnostics
- 8.1.1 Overview
- 8.1.2 Molecular Diagnostics : Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Sepsis Diagnostics Market Analysis – by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
9. Europe Sepsis Diagnostics Market Analysis – by Method
9.1 Automated Diagnostics and Conventional Diagnostics
- 9.1.1 Overview
- 9.1.2 Automated Diagnostics and Conventional Diagnostics: Europe Sepsis Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Sepsis Diagnostics Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Sepsis Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Sepsis Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Sepsis Diagnostics Market Breakdown, by Product
- 10.2.1.1.2 UK: Europe Sepsis Diagnostics Market Breakdown, by Technology
- 10.2.1.1.3 UK: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
- 10.2.1.1.4 UK: Europe Sepsis Diagnostics Market Breakdown, by Method
- 10.2.1.2 Germany:
Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Sepsis Diagnostics Market Breakdown, by Product
- 10.2.1.2.2 Germany: Europe Sepsis Diagnostics Market Breakdown, by Technology
- 10.2.1.2.3 Germany: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
- 10.2.1.2.4 Germany: Europe Sepsis Diagnostics Market Breakdown, by Method
- 10.2.1.3 France:
Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Sepsis Diagnostics Market Breakdown, by Product
- 10.2.1.3.2 France: Europe Sepsis Diagnostics Market Breakdown, by Technology
- 10.2.1.3.3 France: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
- 10.2.1.3.4 France: Europe Sepsis Diagnostics Market Breakdown, by Method
- 10.2.1.4 Russia:
Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Sepsis Diagnostics Market Breakdown, by Product
- 10.2.1.4.2 Russia: Europe Sepsis Diagnostics Market Breakdown, by Technology
- 10.2.1.4.3 Russia: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
- 10.2.1.4.4 Russia: Europe Sepsis Diagnostics Market Breakdown, by Method
- 10.2.1.5 Italy:
Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Sepsis Diagnostics Market Breakdown, by Product
- 10.2.1.5.2 Italy: Europe Sepsis Diagnostics Market Breakdown, by Technology
- 10.2.1.5.3 Italy: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
- 10.2.1.5.4 Italy: Europe Sepsis Diagnostics Market Breakdown, by Method
- 10.2.1.6 Rest of Europe:
Europe Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Product
- 10.2.1.6.2 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Technology
- 10.2.1.6.3 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Flow Cytometry, Microfluidics, Immunoassay, Biomarkers, Microbiology)
- 10.2.1.6.4 Rest of Europe: Europe Sepsis Diagnostics Market Breakdown, by Method
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 F. HOFFMANN-LA ROCHE LTD.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Immunexpress Inc.
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BD
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Danaher (Beckman Coulter)
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Luminex Corporation
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 bioMerieux SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 T2 Biosystems, Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Axis-Shield Diagnostics Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations